DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 120 | -96.8% | 0.00% | – |
| Q3 2019 | $18,000 | -5.3% | 3,790 | +25.4% | 0.00% | – |
| Q2 2019 | $19,000 | +5.6% | 3,023 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -70.5% | 3,023 | -32.1% | 0.00% | -100.0% |
| Q4 2018 | $61,000 | -33.0% | 4,455 | -5.7% | 0.00% | 0.0% |
| Q3 2018 | $91,000 | -8.1% | 4,722 | +20.8% | 0.00% | 0.0% |
| Q2 2018 | $99,000 | +25.3% | 3,910 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $79,000 | -15.1% | 3,937 | -14.8% | 0.00% | 0.0% |
| Q4 2017 | $93,000 | +14.8% | 4,621 | +17.1% | 0.00% | 0.0% |
| Q3 2017 | $81,000 | +252.2% | 3,945 | +155.8% | 0.00% | – |
| Q2 2017 | $23,000 | +21.1% | 1,542 | +33.5% | 0.00% | – |
| Q1 2017 | $19,000 | -75.0% | 1,155 | -80.9% | 0.00% | -100.0% |
| Q4 2016 | $76,000 | -25.5% | 6,044 | +67.2% | 0.00% | 0.0% |
| Q3 2016 | $102,000 | -1.0% | 3,614 | +21.1% | 0.00% | -33.3% |
| Q2 2016 | $103,000 | – | 2,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |